Rates of new or worsening nephropathy were lower in the semaglutide group
For that article we spoke with Albert Li, medical and surgical retina specialist and Clinical Assistant Professor of Ophthalmology at Zucker School of Medicine at Hofstra/Northwell, who had presented data at ARVO indicating that Ozempic was associated with higher rates of DR, as well as other adverse ocular events, when compared to other glucagon-like peptide 1 (GLP-1) receptor agonists, such as Tanzeum, Trulicity, and Victoza
June 2024 Nomenclature and IQVIA Xponent PlanTrak using week-ending 06/21/2024
Journal of Dermatological Science, 53 (1), 1017
GH Secretagogue Characterization Bowers CY (1998) reviewed the history and pharmacology of GHRPs, describing how GHRP-6 was one of the first synthetic peptides shown to release GH through a receptor distinct from the GHRH receptor [2]
The bioenergetic demands of intense performance place substantial loss of ability to regulate energy balance